Compare ICFI & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICFI | TNDM |
|---|---|---|
| Founded | 1969 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2006 | 2013 |
| Metric | ICFI | TNDM |
|---|---|---|
| Price | $86.94 | $16.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 25 |
| Target Price | ★ $107.25 | $27.86 |
| AVG Volume (30 Days) | 159.1K | ★ 2.1M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.64% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.61 | N/A |
| Revenue | ★ $1,229,162,000.00 | $1,014,736,000.00 |
| Revenue This Year | $1.68 | $5.69 |
| Revenue Next Year | $5.88 | $12.35 |
| P/E Ratio | $33.63 | ★ N/A |
| Revenue Growth | 3.72 | ★ 7.93 |
| 52 Week Low | $58.83 | $12.26 |
| 52 Week High | $98.03 | $29.65 |
| Indicator | ICFI | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 57.44 | 43.59 |
| Support Level | $86.43 | $14.54 |
| Resistance Level | $90.96 | $16.50 |
| Average True Range (ATR) | 2.22 | 0.97 |
| MACD | 0.49 | 0.12 |
| Stochastic Oscillator | 85.45 | 57.92 |
ICF International Inc provides professional services and technology-based solutions, including management, technology and policy consulting and implementation services, to government and commercial clients in the U.S. and internationally. Its government clients include U.S. federal agencies, state and local governments and international governments, as well as commercial clients inside and outside the U.S. It supports clients in Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs; and Security and Other Civilian and Commercial markets. The company delivers services across the life cycle of a policy, program or project through Advisory Services, Program Implementation, Analytics Services, Digital Services and Engagement Services.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.